The addition of Brandwood CKC provides PharmaLex with greater visibility in Australia and New Zealand
Frankfurt, Germany – April 20, 2021: PharmaLex Group, a leading provider of specialized services for the pharma, biotech, and MedTech industries worldwide, has completed the merger of Brandwood CKC to the PharmaLex Group
With over 20+ years’ experience, Brandwood CKC is lead by its CEO Grant Bennett. It offers a wide range of regulatory, technical, and commercial services for medical devices and medicinal products in Australia, New Zealand, and the broader APAC region. Based in Sydney, NSW, Brandwood CKC has an international presence in Los Angeles, Wellington, Taipei, and Hong Kong. Their motto ‘Compliance with confidence’ nicely combines with PharmaLex’s ‘Confidence beyond Compliance’ and demonstrates that both companies share the same value proposition, mindset, and culture and act as a trusted partner for the biomedical industry.
“Becoming part of the PharmaLex Group is an exciting step for Brandwood CKC”, explained Grant Bennett, CEO, Brandwood CKC. “It allows us to expand the range of services we can provide to our clients as well as supporting PharmaLex by providing specific expertise in areas such as medical devices”, he added.
“The merger aligns with our objective to strengthen our presence in Australia, New Zealand, and the broader global markets of Asia-Pacific region”, explained Dr. Thomas Dobmeyer, CEO PharmaLex. “Brandwood CKC has a strong client base and coupled with the additional services we offer, we hope this will enable us to gain greater visibility and support our international clients to get their products successfully approved and marketed in this important region”, he concluded.
About PharmaLex <Confidence beyond compliance>:
PharmaLex is a leading provider of specialized services for the pharma, biotech, and medical device industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes, and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.
The PharmaLex Group now has over 1300 employees, with 40 offices in 22 countries and more than 600 satisfied clients worldwide.
For further information, please contact:
Ms. Eva Keck
PharmaLex GmbH; Director, Business Development Operations
+49 621 18 15 38 0